Effects of the Committee on Safety of Medicines Advice on Antidepressant Prescribing to Children and Adolescents in the UK

Author： Murray Macey L.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.28, Iss.12, 2005-01, pp. : 1151-1157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of the Committee on Safety of Medicines Advice on Antidepressant Prescribing to Children and Adolescents in the UK

By Thompson Anne   Nazir Saeed   Sorour Walid  

Drug Safety, Vol. 29, Iss. 6, 2006-01 ,pp. : 549-549

Adis International

Access to resources Recommend Favorite

Safety of medicines in children

By Bush Andrew  

Expert Opinion on Drug Safety, Vol. 2, Iss. 2, 2003-03 ,pp. : 109-112

Informa Healthcare

Access to resources Recommend Favorite

Venlafaxine prescribing advice updated

By  

Inpharma, Vol. 1, Iss. 1541, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

The UK Medicines Control Agency has issued a new safety update for bupropion

By  

Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

General practitioners (GPs) in the UK would consider regular visits from community pharmacists helpful for advice about prescribing issues

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 401, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite